CA-PLUGXR
31.5.2019 20:56:10 CEST | Business Wire | Press release
AWE USA -- PlugXR, Inc., an Augmented Reality (AR) Silicon Valley startup in San Jose, today announced enhancement of its AR Authoring Platform PlugXR Creator, by seamlessly integrating PTC’s Vuforia® Engine platform.
PlugXR Creator & Vuforia SDK
The world-wide market for AR applications is reaching a critical point with leading companies using AR to enhance their products and services. However, the complexities of AR development and resources stifle mass adoption across industries. PlugXR has developed its Creator Platform to bridge this gap, by reducing the time and cost of AR applications development for most markets. This technology will help expand AR development by enabling anyone to create AR experiences in minutes.
Brad Pitser, Director of Product Management, PTC Vuforia, says, “Vuforia Engine provides the ability to leverage consistent performance of AR applications, simultaneously across multiple platforms. Using Vuforia’s powerful and advanced computer-vision SDK, PlugXR Creator allows anyone including developers to make engaging AR applications that can be built and viewed in just minutes.”
“PlugXR partnership with Vuforia enables rapid development and deployment of cost-efficient solutions which can transform industries. Now anyone can create AR apps, in less than an hour, with no coding or scripts. They can also auto-generate .apk (Android) and .ipa (iOS) seamlessly, without installing Android Studio or XCODE and without any additional licensing fees, using our web-based PlugXR Creator,” says Shivaji Yerra, PlugXR Founder & CEO.
PlugXR Creator Subscription
PlugXR Creator includes more advanced features which require absolutely NO Coding for animations, event handlers, custom triggers, CTA, widgets, and multiple object interactions by supporting rich multimedia content like 3D models, 2D images, HD video, audio, buttons, text and more.
PlugXR Creator is available for bundled subscription pricing from June 15, 2019 with 15-days free trial with no additional licensing fees.
About PlugXR
PlugXR, Inc. develops seamless products to accelerate and expand AR market for millions of programmers and non-programmers with NO coding skills to publish new AR Apps or AR experiences in PlugXR App or in existing App in an hour using popular SDKs.
Website: www.plugxr.com
Video:
https://www.youtube.com/watch?v=EqwuOGIbe1g
Brochure:
http://tinyurl.com/yyn77nd7
PTC and Vuforia are trademarks or registered trademarks of PTC Inc. and/or its subsidiaries in the United States and other countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190531005525/en/
Contact:
Mike Raghavan Tel: +1-408-921-1317 Email: sales@plugxr.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom